|
Partnering_Information.pdf - 37 K |
- Amedrix GmbH, Esslingen: Based on a matrix consisting of type I collagen the company Amedrix GmbH develops and produces acellular implants (classified as medical device) for various applications in the human and veterinary sector.
- AmyloCure, Berlin: Small molecule therapeutics/diagnostics for Alzheimer and Huntington.
- Caprotec Bioanalytics GmbH, Berlin: We provide access to a superior technology for analyzing small molecule protein interactions e.g. to reduce adverse drug side effects.
- Cell Medica Limited, London/UK: Pathogenspecific Immunreconstitution in immunocompromised patients.
- CRP GmbH i.P., Berlin: CRP adsorber for myocardial infarction and stroke therapy.
- GHC Global Health Care GmbH, Berlin: Technology and service for a telemedical emergency service for airplanes.
- Humedics GmbH, Grossbeeren: We produce the LiMAxTM / FLIP TM system which is the first device exclusively designed for the real-time assessment of liver function in the exhaled gas flow.
- ILIAS-medical GmbH, Bochum: Mobile, artificial lung, ECMO System
- KINAXO Biotechnologies GmbH, Martinsried: Quantitative analysis of the cellular phosphoproteome to support the development of targeted cancer drugs and companion diagnostics.
- Kirsen Medical Technologies (KMT), Berkeley/ USA: KMT is the leader in Non-Contact Vital Signs Monitoring targeting the $2.4B market with Sleep Diagnostics as initial focus application.
- Medicyte GmbH, Heidelberg: Medicyte is a life science company, seeking further financing in order to leverage the full therapeutic and non-therapeutic potential of its novel high end primary cell products.
- Microstim, Luebeck: Development of a tissue and function preserving myostimulator for muscle powered cardiac assistance.
- Natural Dental Implants AG, Berlin, Early-stage dental technology and services company, making a 100% customized all-ceramic tooth replica, including an anatomically shaped root portion to osseointegrate or to regenerate the periodontal membrane.
- NeMoDevices AG, Kilchberg/Switzerland: NeMoDevices develops new neuromonitoring systems to optimize diagnosis and treatment of patients with stroke and brain injuries.
- NonWoTecc Medical GmbH, Köln: Novel biomimetic vascular prostheses.
- OrganOx Limited, Oxford/UK: A novel medical device for improving the quality and increasing the quantity of organs for transplantation.
- Particular GmbH, Hannover: Particular produces and employs nanoparticles for biomedicine (implant coatings, nanomarkers)
using a new, non-chemical process that stands for large material variety and high purity. - PluriSelelect GmbH, Leipzig: The pluriSelect develops, produces and sales cell separation technology.
- Parelectrics, Berlin: Device for noninvasive skin-cancer diagnostics with the ability to.
- Provecs Medical GmbH, Hamburg: We provide a unique validated platform of combinatorial immunotherapeutics that targets cellular networks in the immune system and delivers products for oncology, vaccines and anti-inflammatories.
- Scaffion, Berlin: Development of protein-interactions for the treatment of chronic heart failure.
- Scopis, Berlin: Scopis and markets measuring for different applications of minimal invasive surgery. The systems are based on specially development measuring sheaths, which upgrade conventional endoscopes toprecise laser measurement.
- SP Solution Pool GmbH, Berlin: Clinical Navigation Systems.
- Zedira GmbH, Darmstadt: Development of a celiac diesease drug until Phase IIa (PoC).
Michael Brandkamp
Stephan Gutzeit
Uwe Maschek
Joachim Rautter
Jens Schneider-Mergener
Klaus Stöckemann
Marco Zeller
Among the investors and institutions supporting entrepreneurs in the Summit were:
- Aescap Venture Management B.V., Amsterdam
- ARCH Venture Partners, San Francisco
- BayTech Venture Capital Beratungs GmbH
- B. Braun Melsungen AG, Melsungen
- Berlin Partner GmbH, Berlin
- Business Angels Network Deutschland, BAND, Essen
- Charité Beteiligungsfonds, Berlin
- Dr. Walter Rust, Business Angel, Berlin
- Dr. Bernd Wegener, Business Angel, Hennigsdorf
- Earlybird, Hamburg
- EXTOREL Private Equity Advisers, Munich
- Filarete Investimenti Spa (Seed Capital), Milan
- Freie Universitaet Berlin, profund, Berlin
- Gazelle Growth Fund, Copenhagen
- GB Unternehmensentwicklung, Charité - Universitaetsmedizin, Berlin
- GO:Incubator, Potsdam
- HealthCap, Stockholm
- High-Tech Gruenderfonds, Bonn
- HUMBOLDT-INNOVATION GmbH, Berlin
- IBB Beteiligungsgesellschaft mbH, Berlin
- Investitionsbank Berlin
- InVivo Biotech Services GmbH, Hennigsdorf
- JStone Innovation Management srl, Torino
- Lodestone IP, London
- Max-Planck-Innovation GmbH, Munich
- Medical Research Council Technology Fund, London
- Novartis Pharma Deutschland, Berlin
- PEPPERMINT. Financial Partners, Berlin
- Pfizer Europe, Berlin
- Pfizer Oncologie Europe
- Philips Healthcare Incubator, Eindhoven
- Projekttraeger Juelich, Berlin
- Proteus Venture Partners, Palo Alto
- Royal Society Enterprise Development Fund, London
- Seventure Partners, Paris
- Sofinnova, Paris
- Sopep, Koeln
- Technische Universitaet Berlin Gruendungsservice, Berlin
- Technologie Transfer, Charité - Universitaetsmedizin, Berlin
- TVM Capital GmbH, Munich
- Ventech, Paris
- VESALIUS BIOCAPITAL, Luxemburg
- Wellcome Trust, London
- Wellington Partners, Munich
If you have any further questions, please do not hesitate to contact our project manager, Ms. Katharina Bergel, by telephone (+49 30 450 570-508) or email.



